XML 27 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
STOCK OPTIONS
9 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK OPTIONS
STOCK OPTIONS
 
Stock Options.

The following table summarizes stock option activity during the nine months ended September 30, 2016:
 
 
Number of
Options
 
Weighted-Average
Exercise Price
Outstanding at January 1, 2016
1,107,794

 
$
3.45

Granted
25,250

 
0.84

Forfeited
(252,589
)
 
3.28

Outstanding at September 30, 2016
880,455

 
$
3.39

Exercisable at September 30, 2016
574,650

 
$
4.08


    
During the nine months ended September 30, 2016, we granted options to purchase 25,250 shares of our common stock at a weighted-average exercise price of $0.84 per share under our 2006 Equity Incentive Plan, as amended (the “Plan”). Options to purchase an aggregate of 641,560 shares of our common stock were granted during the nine months ended September 30, 2015.

As of September 30, 2016, there were 574,650 options exercisable and 860,411 options that were vested or expected to vest with an aggregate intrinsic value of zero.

Stock Appreciation Rights (SARs)

The following table summarizes SARs activity under the Plan during the nine months ended September 30, 2016:
 
Number of
SARs
 
Weighted-Average
Exercise Price
Outstanding at January 1, 2016
98,333

 
$
4.14

Outstanding at September 30, 2016
98,333

 
$
4.14

Exercisable at September 30, 2016
92,558

 
$
4.20



All outstanding SARs were issued solely to our executive officers.

As of September 30, 2016, 92,558 shares subject to outstanding SARs were exercisable and 98,333 shares were vested or expected to vest. The weighted-average exercise price of these SARs was $4.14 per share and the aggregate intrinsic value was zero.